» Articles » PMID: 23747198

Essential Roles of Leu/Ile/Phe-rich Domain of JC Virus Agnoprotein in Dimer/oligomer Formation, Protein Stability and Splicing of Viral Transcripts

Overview
Journal Virology
Specialty Microbiology
Date 2013 Jun 11
PMID 23747198
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Agnoprotein is one of the key regulatory proteins of polyomaviruses, including JCV, BKV and SV40 and is required for a productive viral life cycle. We have recently reported that agnoprotein forms stable dimer/oligomers mediated by a predicted amphipathic α-helix, spanning amino acids (aa), 17 to 42. Deletion of the α-helix renders a replication incompetent virus. Here, we have further characterized this region by a systematic deletion and substitution mutagenesis and demonstrated that a Leu/Ile/Phe-rich domain, (spanning aa 28-39) within α-helix is indispensable for agnoprotein structure and function. Deletion of aa 30-37 severely affects the dimer/oligomer formation and stable expression of the protein. Mutagenesis data also indicate that the residues, 34-36, may be involved in regulation of the splicing events of JCV transcripts. Collectively, these data suggest that the Leu/Ile/Phe-rich domain plays critical roles in agnoprotein function and thus represents a potential target for developing novel therapeutics against JCV infections.

Citing Articles

Target-specific peptides for BK virus agnoprotein identified through phage display screening: advancing antiviral therapeutics.

Xing X, Han J, Wang K, Tian F, Jiang C, Liang W Sci Rep. 2025; 15(1):2718.

PMID: 39837922 PMC: 11750963. DOI: 10.1038/s41598-025-86439-4.


Prediction of Prospective Mutational Landscape of SARS-CoV-2 Spike ssRNA and Evolutionary Basis of Its Host Interaction.

Sarkar A, Ghosh T, Bandyopadhyay B, Maiti S, Panja A Mol Biotechnol. 2024; .

PMID: 38619800 DOI: 10.1007/s12033-024-01146-1.


Human neurotropic polyomavirus, JC virus, late coding region encodes a novel nuclear protein, ORF4, which targets the promyelocytic leukemia nuclear bodies (PML-NBs) and modulates their reorganization.

Saribas A, Bellizzi A, Wollebo H, Beer T, Tang H, Safak M Virology. 2023; 587:109866.

PMID: 37741199 PMC: 10602023. DOI: 10.1016/j.virol.2023.109866.


The oncogenic roles of JC polyomavirus in cancer.

Zheng H, Xue H, Zhang C Front Oncol. 2022; 12:976577.

PMID: 36212474 PMC: 9537617. DOI: 10.3389/fonc.2022.976577.


Human neurotropic polyomavirus, JC virus, agnoprotein targets mitochondrion and modulates its functions.

Saxena R, Saribas S, Jadiya P, Tomar D, Kaminski R, Elrod J Virology. 2020; 553:135-153.

PMID: 33278736 PMC: 7847276. DOI: 10.1016/j.virol.2020.11.004.


References
1.
Sariyer I, Khalili K, Safak M . Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology. 2008; 375(2):464-79. PMC: 2739041. DOI: 10.1016/j.virol.2008.02.020. View

2.
Lu J, Sharpe S, Ghirlando R, Yau W, Tycko R . Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci. 2010; 19(10):1877-96. PMC: 2998723. DOI: 10.1002/pro.474. View

3.
Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S . Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst. 2002; 94(4):267-73. DOI: 10.1093/jnci/94.4.267. View

4.
Safak M, Sadowska B, Barrucco R, Khalili K . Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol. 2002; 76(8):3828-38. PMC: 136065. DOI: 10.1128/jvi.76.8.3828-3838.2002. View

5.
Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A, Khalili K . Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene. 2002; 21(36):5574-81. DOI: 10.1038/sj.onc.1205744. View